Circulating microRNA Biomarkers of Thiazide Response in Hypertension.
Circulating microRNA Biomarkers of Thiazide Response in Hypertension. J Am Heart Assoc. 2024 Feb 20; 13(4):e032433.
PMID: 38353215
Cardiac Localized Polycystin-2 plays a Functional Role in Natriuretic Peptide Production and its Absence Contributes to Hypertension.
Cardiac Localized Polycystin-2 plays a Functional Role in Natriuretic Peptide Production and its Absence Contributes to Hypertension. bioRxiv. 2024 Jan 02.
PMID: 38260706
Magnetic resonance imaging preprocessing and radiomic features for classification of autosomal dominant polycystic kidney disease genotype.
Magnetic resonance imaging preprocessing and radiomic features for classification of autosomal dominant polycystic kidney disease genotype. J Med Imaging (Bellingham). 2023 Nov; 10(6):064503.
PMID: 38156331
All Patients with ADPKD Should Undergo Screening for Intracranial Aneurysms: COMMENTARY.
All Patients with ADPKD Should Undergo Screening for Intracranial Aneurysms: COMMENTARY. Kidney360. 2023 Nov 22.
PMID: 37990357
Pregnancy in Autosomal Dominant Polycystic Kidney Disease.
Pregnancy in Autosomal Dominant Polycystic Kidney Disease. Adv Kidney Dis Health. 2023 Sep; 30(5):454-460.
PMID: 38032583
OVERTURE: A Worldwide, Prospective, Observational Study of Disease Characteristics in Patients With ADPKD.
OVERTURE: A Worldwide, Prospective, Observational Study of Disease Characteristics in Patients With ADPKD. Kidney Int Rep. 2023 May; 8(5):989-1001.
PMID: 37180499
Utility of new image-derived biomarkers for autosomal dominant polycystic kidney disease prognosis using automated instance cyst segmentation.
Utility of new image-derived biomarkers for autosomal dominant polycystic kidney disease prognosis using automated instance cyst segmentation. Kidney Int. 2023 08; 104(2):334-342.
PMID: 36736536
Venglustat, a Novel Glucosylceramide Synthase Inhibitor, in Patients at Risk of Rapidly Progressing ADPKD: Primary Results of a Double-Blind, Placebo-Controlled, Phase 2/3 Randomized Clinical Trial.
Venglustat, a Novel Glucosylceramide Synthase Inhibitor, in Patients at Risk of Rapidly Progressing ADPKD: Primary Results of a Double-Blind, Placebo-Controlled, Phase 2/3 Randomized Clinical Trial. Am J Kidney Dis. 2023 05; 81(5):517-527.e1.
PMID: 36535535
Measuring Copeptin, a surrogate for Vasopressin in Patients with Hypertension - Can it identify those who are Volume Responsive?
Measuring Copeptin, a surrogate for Vasopressin in Patients with Hypertension - Can it identify those who are Volume Responsive? Clin Biochem. 2022 Dec 02.
PMID: 36470342
Effects of Bardoxolone Methyl in Alport Syndrome.
Effects of Bardoxolone Methyl in Alport Syndrome. Clin J Am Soc Nephrol. 2022 12; 17(12):1763-1774.
PMID: 36411058